Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amylyx Pharmaceuticals (AMLX) Return on Assets (2022 - 2025)

Amylyx Pharmaceuticals has reported Return on Assets over the past 4 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Assets at 0.0% for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (changed 0.0% YoY), and the annual figure for FY2025 was 0.0%, changed 0.0%.
  • Return on Assets for Q4 2025 was 0.0% at Amylyx Pharmaceuticals, down from 0.55% in the prior quarter.
  • Over the last five years, Return on Assets for AMLX hit a ceiling of 0.55% in Q2 2025 and a floor of 0.9% in Q3 2022.
  • Median Return on Assets over the past 4 years was 0.0% (2024), compared with a mean of 0.07%.
  • Biggest five-year swings in Return on Assets: tumbled -131bps in 2024 and later skyrocketed 142bps in 2025.
  • Amylyx Pharmaceuticals' Return on Assets stood at 0.0% in 2022, then surged by 9297bps to 0.11% in 2023, then tumbled by -100bps to 0.0% in 2024, then tumbled by -821bps to 0.0% in 2025.
  • The last three reported values for Return on Assets were 0.0% (Q4 2025), 0.55% (Q3 2025), and 0.55% (Q2 2025) per Business Quant data.